SEC filings and other documents

Q2 2026 EBITDA rose 12% year-over-year, with a $20B+ project backlog and strong demand outlook.

All business items passed amid strong financials, disciplined growth, and enhanced indigenous oversight.

Record Q1 EBITDA growth and robust project backlog support strong long-term outlook.

Q4 EBITDA rose 13% year-over-year, with strong execution and robust growth outlook reaffirmed.

Q3 EBITDA up 10% year-over-year; strong growth outlook and disciplined capital execution continue.

Q2 EBITDA up 12% year-over-year; guidance raised, with strong growth and deleveraging ahead.

All business items passed, with renewed strategic focus and a 3.3% dividend increase announced.

Record Q1 throughput, under-budget projects, and robust growth pipeline drive strong outlook.

2024 saw strong EBITDA growth, a major pipeline milestone, and a 3.3% dividend hike.